Georgia Bio Receives Increase in State Funds for Teacher Training Initiative and Reveals Most Recent Impact Numbers

The program has reached 81,413 students and 519 teachers across Georgia.

Atlanta, GA (August 5, 2024) – Georgia Bio’s Biotech Teacher Training Initiative (BTTI), formerly known as the Rural Teacher Training Initiative (RTTI), secured a significant increase in state funding in Georgia’s Fiscal Year 2025 budget. Total state funding now sits at $500,000. This investment from the state will be matched by industry donations in both cash and equipment, bringing the value of this program to $1+ million. Prior to receiving this increase in funding, the program conducted its fifth year of career-relevant instruction via hands-on teacher learning, impacting nearly 30,000 students and 150 teachers. In its first five years, the program has reached 81,413 students and 519 teachers across Georgia. Going forward, in conjunction with the additional funding and gifts from industry, BTTI will be able expand its operations in the urban areas of the state, impacting even more teachers and students.


This programmatic increase will support several initiatives, including hosting an additional cohort of teachers annually in an urban area where the density of industry sits, such as Atlanta or Augusta, and expanding the Equipment Depot and access to lab equipment. Plans for increased access include opening one satellite science equipment loaning office in Northwest Georgia, developing a shipment option with matching private funding, and potential for another satellite location in South Georgia. Further, funds will be allocated toward collaborating with Southwest Georgia RESA to provide teacher training for new science teachers in areas struggling to fill teacher positions, offer training and career path information for guidance counselors on opportunities in the life sciences, explore curriculum enhancement to include medical devices, and network with existing teachers.  

 

“Georgia Bio is the only organization in the State that offers this type of hands-on training program, complemented with classroom supplies and access to career pathway understanding,” said Maria Thacker-Goethe, President and CEO of Georgia Bio. “Investing in improving access to resources for educators can open life changing careers for students and be a boon to Georgia’s economy, and this increase in funding signifies that the State agrees. As the industry continues its rapid growth across the state, our companies need to know there is a workforce pipeline being developed and we help innovatively address that need. I am excited for the future of BTTI and grateful for the support of the State and members of our industry as we endeavor to build upon this program’s value and success.”


“With the explosive growth in biotechnology has come the heightened need for a qualified workforce,” says BTTI Instructor Stan Harrison, also Biotech Pathway Teacher at the Athens Community Career Academy and State Coordinator for the Biotechnician-Assistant Credentialing Exam (BACE). “We hear it echoed again and again that companies are struggling to hire and retain qualified production staff and therefore unable to manufacture high demand and often life-saving products. Quality training starts with highly trained secondary teachers who understand industry recognized standards. Georgia Bio’s BTTI provides a host of professional learning workshops and along with the Equipment Depot, a structured means to network and access cutting edge materials for modern lab training.”


BTTI is a public/private workforce development partnership between the life sciences sector and the State of Georgia. Led by Program Director, Megan Heaphy, BTTI offers hands-on, immersive science teacher professional development for Georgia teachers state-wide. Curriculum is built to highlight and leverage the biotechnology that exists within traditional science courses, including biology and AP biology, chemistry and AP chemistry, physics, environmental biology, agriculture and horticulture, physical science, and life science.


About Georgia Bio 

Georgia Bio (GaBio) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For over 30 years, GaBio has served its members by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in biotechnology, pharmaceuticals, and medical technology. GaBio also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. GaBio works to shape public policy, improve access to breakthrough technologies, educate lawmakers, provide member programs, strengthens the workforce pipeline, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. For more information, visit www.gabio.org

 

MEDIA CONTACT: 

Melissa Carter 

404-920-2043 

mcarter@gabio.org 

August 17, 2026
Biotechnology Innovation Organization (BIO) Senior Vice President of Science & Regulatory Affairs Annetta Beauregard issued the following statement on the release of the Prescription Drug User Fee Act (PDUFA) VIII commitment letter: “For more than 30 years, PDUFA has helped deliver hundreds of new medicines to American patients. As a lead industry negotiator for the PDUFA VIII agreement, BIO supports the PDUFA VIII commitment letter and its strengthening of regulatory review, advancing innovation, and helping deliver safe and effective treatments to patients. “Specifically, the PDUFA VIII agreement includes important commitments that bolster the FDA’s core review activities, ensure accountability for predictable performance, improve financial sustainability and improve communication, transparency and efficiency. “Timely, bipartisan reauthorization of PDUFA is vital for protecting the health of Americans, strengthening U.S. competitiveness, and maintaining America’s global leadership in medical innovation. BIO is committed to working with Congress to ensure reauthorization by September 30, 2027.” The FDA has announced plans to hold a hybrid public meeting at 9am on 9/16 to discuss the proposed enhancements for the reauthorization of PDUFA for fiscal years (FYs) 2028 through 2033. Learn More about PDUFA and the PDUFA VIII commitment letter HERE .
August 10, 2026
Award recipients will be recognized at the Golden Helix Awards Ceremony on August 25 ATLANTA, Ga. – Georgia Life Sciences today announced the recipients of the 2026 Golden Helix Awards, recognizing the individuals, organizations, partnerships, and investments that are advancing innovation, improving patient care, strengthening Georgia's economy, and shaping the future of the state's life sciences ecosystem. The honorees will be celebrated during the Georgia Life Sciences Summit Welcome Reception and Golden Helix Awards Ceremony on Tuesday, August 25, at the Sandy Springs Performing Arts Center, kicking off Georgia's premier gathering of life sciences leaders ahead of the Summit on Wednesday, August 26. "For nearly two decades, the Golden Helix Awards have celebrated the people and organizations whose vision, collaboration, and commitment continue to elevate Georgia as a global leader in life sciences," said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. "This year's recipients represent the extraordinary innovation taking place across our state—from groundbreaking research and transformative investments to workforce development and community impact. We are proud to recognize their achievements and the lasting difference they are making for patients, our economy, and the future of healthcare." 2026 Golden Helix Award Honorees Phoenix Award · Micron Biomedical, Emory University, and CDC – Industry-Academic Partnership Innovation Awards · Dr. Kyle Johnsen, University of Georgia · Focused Cryo Community Awards · Angela Gill Nelms, Biolocity · Frugal Science Academy · Jessica King Holden, Gwinnett Regional Science, Engineering + Innovation Fair · Dr. Marlo Vernon, Augusta University Deal of the Year Awards Economic Development · UCB · Shriners Children's Research Institute and Georgia Tech Acquisition · LymphaTech & Tactile Medical · Avanos Medical Financing · Altesa BioSciences Federal Grant · HEAL: Healthy Ameliorated Lymphatics, Georgia Institute of Technology · Manus & U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (HHS/ASPR) Emerging Leader of the Year · Dr. Ryan Devine, Medical Innovation Hub, Georgia Tech Legislator of the Year · Rep. Matt Dubnik (R-29) Teacher of the Year · Ana White, DeKalb High School of Technology North at Cross Keys The Golden Helix Awards recognize excellence across Georgia's life sciences ecosystem, honoring breakthrough scientific discoveries, strategic partnerships, commercial achievements, community leadership, and investments that strengthen the state's position as a national leader in biotechnology, medical technology, pharmaceuticals, research, and advanced manufacturing. The awards ceremony serves as the opening event of the 2026 Georgia Life Sciences Summit, bringing together executives, researchers, entrepreneurs, investors, and healthcare leaders, and academic institutions from across the state to celebrate innovation and explore opportunities shaping the future of Georgia's life sciences industry. The Georgia Life Sciences Summit will take place on Wednesday, August 26, at the Sandy Springs Performing Arts Center, featuring nationally recognized speakers, executive panels, CEO spotlights, networking opportunities, and the Solutions Corridor showcasing organizations driving the industry's continued growth. To learn more about the Georgia Life Sciences Summit or to register, visit https://www.galifesciences.org/summit.
August 7, 2026
One of the biggest benefits of becoming a Georgia Life Sciences Student Member is access to discounted registration for Georgia's premier life sciences conference—bringing together CEOs, researchers, entrepreneurs, investors, and innovators from across the state. Better yet, Student Membership is only $25 per year , making it one of the best investments you can make in your future. The Georgia Life Sciences Emerging Leaders Network (ELN) is the official student membership community of Georgia Life Sciences, created to connect students, postdoctoral researchers, and early-career professionals with Georgia's thriving life sciences ecosystem. As an ELN member, you'll build meaningful peer-to-peer relationships, engage with industry leaders, explore career opportunities, and gain access to professional development programs designed to help you launch a successful career in the life sciences. As a member, you'll have opportunities to: Connect with fellow students, postdocs, and emerging professionals from across Georgia. Expand your network through peer-to-peer engagement and professional networking events. Learn from industry leaders and gain exposure to Georgia's life sciences ecosystem. Participate in workforce and career development programming. Access Career Connections Student members also receive exclusive access to the Georgia Life Sciences Career Connections LinkedIn Group , where you can: Discover internships and job opportunities. Connect with employers, recruiters, and industry professionals. Stay informed about career fairs, networking events, and workforce initiatives. Engage with a growing community of future life sciences leaders. Student Member Benefits Georgia Life Sciences Student Membership: $25/year Georgia Life Sciences Summit Registration: $150 Access to the Emerging Leaders Network Career Connections LinkedIn Group Networking events and professional development opportunities Industry news, workforce resources, and member communications Whether you're exploring careers in biotechnology, medical devices, pharmaceuticals, diagnostics, digital health, or research, Georgia Life Sciences connects you to the people and opportunities that can help shape your future. Join today . Build your network. Advance your career.
MORE POSTS